Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Administering Fibroblasts to Regenerate Tissue in Treatment of Degenerative Disc Disease and MS with Hamid Khoja FibroBiologics TRANSCRIPT
Download PDFFeb 22, 2022
Hamid Khoja is the Chief Scientific Officer of FibroBiologics which is developing regenerative medicine using fibroblasts which are one of the most abundant cells in the human body. While stem cell therapy has gotten significant attention, fibroblasts are easier to source and grow.
Hamid elaborates, "Just to give you a sense of some of the capabilities of fibroblasts. They behave very similarly in many aspects to stem cells, which we're very well aware of. What makes fibroblasts significantly interesting for us and for therapeutic purposes is that they can also differentiate into many different cell types."
"So the CybroCell is the product name that we've given our tolerogenic fibroblasts, cells that have been specifically cultured for use in degenerative disc disease. But we've also tested this same product in a clinical trial for multiple sclerosis. So we have done limited trials for safety for both degenerative disc disease and multiple sclerosis, and the results have been very promising."
#FibroBiologics #Fibroblasts #DegenerativeDiscDisease #DDD #MultipleSclerosis #MS #MultipleSclerosisTreatment #StemCellAlternative
